Search research articles
Contact Us
Filters
Showing results (71-80 of 176) with videos related to
Page
of 18
Sort By:
American Journal of Hematology
|
April 17, 2021
Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Laure Philippe Walter, Lucile Couronné, Jean-Philippe Jais, et al.
Blood
|
June 26, 2012
Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival
Marie-Thérèse Rubio, Lucia Moreira-Teixeira, Emmanuel Bachy, et al.
Frontiers in Oncology
|
November 15, 2024
End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy
Pierre Sesques, Lionel Karlin, Emmanuel Massy, et al.
Blood Advances
|
January 5, 2024
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality
Kai Rejeski, Yucai Wang, Doris K Hansen, et al.
Annals of Hematology
|
October 11, 2017
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma
Emilie Fargier, Florence Ranchon, Laure Huot, et al.
Hematological Oncology
|
January 19, 2020
Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era
Pierre Sesques, Jessie Bourcier, Camille Golfier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2018
Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts
Clémentine Sarkozy, Matthew J Maurer, Brian K Link, et al.
Hematological Oncology
|
July 11, 2024
Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital
Caroline Le Lan, Aurélien Belot, Camille Golfier, et al.
The Lancet. Haematology
|
December 22, 2015
Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study
Jehan Dupuis, Franck Morschhauser, Hervé Ghesquières, et al.
Haematologica
|
November 13, 2012
Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy
Tereza Coman, Emmanuel Bachy, Mauricette Michallet, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 176) with videos related to
Sort By:
Page
of 18
American Journal of Hematology
|
April 17, 2021
Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Laure Philippe Walter, Lucile Couronné, Jean-Philippe Jais, et al.
Blood
|
June 26, 2012
Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival
Marie-Thérèse Rubio, Lucia Moreira-Teixeira, Emmanuel Bachy, et al.
Frontiers in Oncology
|
November 15, 2024
End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy
Pierre Sesques, Lionel Karlin, Emmanuel Massy, et al.
Blood Advances
|
January 5, 2024
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality
Kai Rejeski, Yucai Wang, Doris K Hansen, et al.
Annals of Hematology
|
October 11, 2017
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma
Emilie Fargier, Florence Ranchon, Laure Huot, et al.
Hematological Oncology
|
January 19, 2020
Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era
Pierre Sesques, Jessie Bourcier, Camille Golfier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 28, 2018
Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts
Clémentine Sarkozy, Matthew J Maurer, Brian K Link, et al.
Hematological Oncology
|
July 11, 2024
Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital
Caroline Le Lan, Aurélien Belot, Camille Golfier, et al.
The Lancet. Haematology
|
December 22, 2015
Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study
Jehan Dupuis, Franck Morschhauser, Hervé Ghesquières, et al.
Haematologica
|
November 13, 2012
Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy
Tereza Coman, Emmanuel Bachy, Mauricette Michallet, et al.
Page
of 18